vs

Side-by-side financial comparison of INSMED Inc (INSM) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.

INSMED Inc is the larger business by last-quarter revenue ($263.8M vs $194.8M, roughly 1.4× TOMPKINS FINANCIAL CORP). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs -124.5%, a 173.9% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs 152.6%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $-264.2M). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs 63.6%).

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.

INSM vs TMP — Head-to-Head

Bigger by revenue
INSM
INSM
1.4× larger
INSM
$263.8M
$194.8M
TMP
Growing faster (revenue YoY)
TMP
TMP
+0.0% gap
TMP
152.7%
152.6%
INSM
Higher net margin
TMP
TMP
173.9% more per $
TMP
49.4%
-124.5%
INSM
More free cash flow
TMP
TMP
$296.1M more FCF
TMP
$31.9M
$-264.2M
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
63.6%
TMP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INSM
INSM
TMP
TMP
Revenue
$263.8M
$194.8M
Net Profit
$-328.5M
$96.2M
Gross Margin
83.2%
Operating Margin
-121.2%
71.7%
Net Margin
-124.5%
49.4%
Revenue YoY
152.6%
152.7%
Net Profit YoY
-39.5%
388.9%
EPS (diluted)
$-1.55
$6.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSM
INSM
TMP
TMP
Q4 25
$263.8M
$194.8M
Q3 25
$142.3M
$87.4M
Q2 25
$107.4M
$82.6M
Q1 25
$92.8M
$81.7M
Q4 24
$104.4M
$77.1M
Q3 24
$93.4M
$76.6M
Q2 24
$90.3M
$72.7M
Q1 24
$75.5M
$72.8M
Net Profit
INSM
INSM
TMP
TMP
Q4 25
$-328.5M
$96.2M
Q3 25
$-370.0M
$23.7M
Q2 25
$-321.7M
$21.5M
Q1 25
$-256.6M
$19.7M
Q4 24
$-235.5M
$19.7M
Q3 24
$-220.5M
$18.6M
Q2 24
$-300.6M
$15.7M
Q1 24
$-157.1M
$16.9M
Gross Margin
INSM
INSM
TMP
TMP
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
75.0%
Q3 24
77.3%
Q2 24
76.8%
Q1 24
76.9%
Operating Margin
INSM
INSM
TMP
TMP
Q4 25
-121.2%
71.7%
Q3 25
-257.1%
35.6%
Q2 25
-291.3%
34.2%
Q1 25
-267.3%
31.6%
Q4 24
-220.6%
33.4%
Q3 24
-228.4%
32.0%
Q2 24
-319.8%
28.3%
Q1 24
-192.7%
30.4%
Net Margin
INSM
INSM
TMP
TMP
Q4 25
-124.5%
49.4%
Q3 25
-260.0%
27.1%
Q2 25
-299.5%
26.0%
Q1 25
-276.4%
24.1%
Q4 24
-225.5%
25.5%
Q3 24
-236.0%
24.3%
Q2 24
-332.8%
21.6%
Q1 24
-208.1%
23.2%
EPS (diluted)
INSM
INSM
TMP
TMP
Q4 25
$-1.55
$6.72
Q3 25
$-1.75
$1.65
Q2 25
$-1.70
$1.50
Q1 25
$-1.42
$1.37
Q4 24
$-1.30
$1.39
Q3 24
$-1.27
$1.30
Q2 24
$-1.94
$1.10
Q1 24
$-1.06
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSM
INSM
TMP
TMP
Cash + ST InvestmentsLiquidity on hand
$1.4B
$132.8M
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$739.0M
$938.4M
Total Assets
$2.3B
$8.7B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSM
INSM
TMP
TMP
Q4 25
$1.4B
$132.8M
Q3 25
$1.7B
$193.5M
Q2 25
$1.9B
$212.6M
Q1 25
$1.2B
$193.1M
Q4 24
$1.4B
$134.4M
Q3 24
$1.5B
$132.3M
Q2 24
$1.2B
$70.9M
Q1 24
$595.7M
$57.1M
Total Debt
INSM
INSM
TMP
TMP
Q4 25
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$971.8M
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
INSM
INSM
TMP
TMP
Q4 25
$739.0M
$938.4M
Q3 25
$945.6M
$788.8M
Q2 25
$1.2B
$761.8M
Q1 25
$99.2M
$741.4M
Q4 24
$285.4M
$713.4M
Q3 24
$483.4M
$719.9M
Q2 24
$38.8M
$674.6M
Q1 24
$-464.8M
$667.9M
Total Assets
INSM
INSM
TMP
TMP
Q4 25
$2.3B
$8.7B
Q3 25
$2.4B
$8.5B
Q2 25
$2.5B
$8.4B
Q1 25
$1.8B
$8.2B
Q4 24
$2.0B
$8.1B
Q3 24
$2.1B
$8.0B
Q2 24
$1.8B
$7.9B
Q1 24
$1.2B
$7.8B
Debt / Equity
INSM
INSM
TMP
TMP
Q4 25
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
3.93×
Q3 24
2.01×
Q2 24
30.66×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSM
INSM
TMP
TMP
Operating Cash FlowLast quarter
$-247.6M
$38.9M
Free Cash FlowOCF − Capex
$-264.2M
$31.9M
FCF MarginFCF / Revenue
-100.1%
16.4%
Capex IntensityCapex / Revenue
6.3%
3.6%
Cash ConversionOCF / Net Profit
0.40×
TTM Free Cash FlowTrailing 4 quarters
$-967.6M
$105.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSM
INSM
TMP
TMP
Q4 25
$-247.6M
$38.9M
Q3 25
$-219.8M
$34.9M
Q2 25
$-205.6M
$18.9M
Q1 25
$-262.1M
$22.2M
Q4 24
$-196.0M
$95.0M
Q3 24
$-180.9M
$21.2M
Q2 24
$-123.0M
$27.3M
Q1 24
$-184.0M
$23.2M
Free Cash Flow
INSM
INSM
TMP
TMP
Q4 25
$-264.2M
$31.9M
Q3 25
$-222.2M
$33.9M
Q2 25
$-209.1M
$18.3M
Q1 25
$-272.2M
$20.9M
Q4 24
$-202.8M
$88.8M
Q3 24
$-184.6M
$18.9M
Q2 24
$-129.7M
$26.3M
Q1 24
$-188.7M
$21.9M
FCF Margin
INSM
INSM
TMP
TMP
Q4 25
-100.1%
16.4%
Q3 25
-156.1%
38.8%
Q2 25
-194.6%
22.1%
Q1 25
-293.2%
25.5%
Q4 24
-194.1%
115.1%
Q3 24
-197.6%
24.7%
Q2 24
-143.6%
36.2%
Q1 24
-250.0%
30.0%
Capex Intensity
INSM
INSM
TMP
TMP
Q4 25
6.3%
3.6%
Q3 25
1.7%
1.1%
Q2 25
3.2%
0.8%
Q1 25
10.8%
1.7%
Q4 24
6.5%
8.1%
Q3 24
3.9%
2.9%
Q2 24
7.5%
1.3%
Q1 24
6.2%
1.9%
Cash Conversion
INSM
INSM
TMP
TMP
Q4 25
0.40×
Q3 25
1.47×
Q2 25
0.88×
Q1 25
1.13×
Q4 24
4.82×
Q3 24
1.14×
Q2 24
1.74×
Q1 24
1.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons